Salmonella enterica serovar Enteritidis is one of the most prevalent Salmonella serovars in poultry and is often associated with human salmonellosis. S. Enteritidis is known to suppress nitric oxide (NO) production in infected chicken macrophage HD11 cells, while dead S. Enteritidis stimulates a high level of NO production, suggesting a bacterial inhibitory effect on NO production. Based on these observations, the present study was conducted to evaluate whether NO production in S. Enteritidis-infected HD11 cells can be used as a biomarker to identify molecules that kill intracellular Salmonella. Since Salmonella are known to manipulate the host cell kinase network to facilitate intracellular survival, we screened a group of pharmaceutical inhibitors of various kinases to test our hypothesis. A protein kinase A inhibitor, H-89, was found to reverse the suppression of NO production in S. Enteritidis-infected HD11 cells. Production of NO in S. Enteritidis-infected HD11 cells increased significantly following treatment with H-89 at or above 20 μM. Inversely, the number of viable intracellular Salmonella decreased significantly in cells treated with H-89 at or above 30 μM. Furthermore, the growth rate of S. Enteritidis in culture was significantly inhibited by H-89 at concentrations from 20 to 100 μM. Our results demonstrate that NO-based screening using S. Enteritidis-infected HD11 cells is a viable tool to identify chemicals with anti-intracellular Salmonella activity. Using this method, we have shown H-89 has bacteriostatic activity against Salmonella, independent of host cell protein kinase A or Akt1 activity.
References
[1]
Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson M-A, et al. (2011) Foodborne illness acquired in the United States–major pathogens. Emerg Infect Dis 17: 7–15.
[2]
Shames SR, Auweter SD, Finlay BB (2009) Co-evolution and exploitation of host cell signaling pathways by bacterial pathogens. Int J Biochem Cell Biol 41: 380–9.
[3]
Haraga A, Ohlson MB, Miller SI (2008) Salmonellae interplay with host cells. Nat Rev Microbiol 6: 53–66.
[4]
Ibarra JA, Steele-Mortimer O (2009) Salmonella – the ultimate insider. Salmonella virulence factors that modulate intracellular survival. Cell Microbiol 11: 1579–86.
[5]
Malik-Kale P, Jolly CE, Lathrop S, Winfree S, Luterbach C, et al. (2011) Salmonella - at home in the host cell. Front Microbiol 2: 125 doi:10.3389/fmicb.2011.00125.
[6]
Alcaine SD, Warnick LD, Wiedmann M (2007) Antimicrobial resistance in nontyphoidal Salmonella. J Food Prot 70: 780–90.
[7]
Foley SL, Lynne AM (2008) Food animal-associated Salmonella challenges: pathogenicity and antimicrobial resistance. J Anim Sci 86: E173–87.
[8]
Lathers CM (2001) Role of veterinary medicine in public health: antibiotic use in food animals and humans and the effect on evolution of antibacterial resistance. J Clin Pharmacol 41: 595–9.
[9]
CDC (2008) Salmonella Surveillance: Annual Summary, 2006. US Department of Health and Human Services, CDC, Atlanta, GA.
[10]
FDA (2010) National Antimicrobial Resistance Monitoring System–enteric bacteria (NARMS): 2007 executive report. U.S. Department of Health and Human Services, FDA, Rockville, MD.
[11]
Gast RK, Guard-Bouldin J, Holt PS (2004) Colonization of reproductive organs and internal contamination of eggs after experimental infection of laying hens with Salmonella heidelberg and Salmonella enteritidis. Avian Dis 48: 863–9.
[12]
Gantois I, Eeckhaut V, Pasmans F, Haesebrouck F, Ducatelle R, et al. (2008) A comparative study on the pathogenesis of egg contamination by different serotypes of Salmonella. Avian Pathol 37: 399–406.
[13]
He H, Genovese KJ, Kogut MH (2011) Modulation of chicken macrophage effector function by T(H)1/T(H)2 cytokines. Cytokine 53: 363–9.
[14]
He H, Genovese KJ, Swaggerty CL, Nisbet DJ, Kogut MH (2012) A comparative study on invasion, survival, modulation of oxidative burst and nitric oxide responses of macrophages (HD11), and systemic infection in chickens by prevalent poultry Salmonella serovars. Foodborne Pathog Dis 9: 1104–10.
[15]
Kogut MH, McGruder ED, Hargis BM, Corrier DE, DeLoach JR (1995) In vivo activation of heterophil function in chickens following injection with Salmonella enteritidis-immune lymphokines. J Leukoc Biol 57: 56–62.
[16]
Beug H, von Kirchbach A, D？derlein G, Conscience JF, Graf T (1979) Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 18: 375–90.
[17]
Green L, Wagner D, Glogowski J, Skipper P, Wishnok J, et al. (1982) Analysis of nitrate, nitrite and [15 N] nitrate in biological fluids. Analyt Biochem 126: 131–8.
[18]
McGhie EJ, Brawn LC, Hume PJ, Humphreys D, Koronakis V (2009) Salmonella takes control: effector-driven manipulation of the host. Curr Opin Microbiol 12: 117–24.
[19]
Thomas DD, Ridnour LA, Isenberg JS, Flores-Santana W, Switzer CH, et al. (2008) The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med 45: 18–31.
[20]
MacMicking J, Xie QW, Nathan C (1997) Nitric oxide and macrophage function. Annu Rev Immunol 15: 323–50.
[21]
Mastroeni P, Vazquez-Torres A, Fang FC, Xu Y, Khan S, et al. (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J Exp Med 192: 237–48.
[22]
Alam MS, Akaike T, Okamoto S, Kubota T, Yoshitake J, et al. (2002) Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immun 70: 3130–42.
[23]
Alam MS, Zaki MH, Sawa T, Islam S, Ahmed KA, et al. (2008) Nitric oxide produced in Peyer's patches exhibits antiapoptotic activity contributing to an antimicrobial effect in murine salmonellosis. Microbiol Immunol 52: 197–208.
[24]
Das P, Lahiri A, Lahiri A, Chakravortty D (2009) Novel role of the nitrite transporter NirC in Salmonella pathogenesis: SPI2-dependent suppression of inducible nitric oxide synthase in activated macrophages. Microbiology 155: 2476–89.
[25]
Chakravortty D, Hansen-Wester I, Hensel M (2002) Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med 195: 1155–66.
[26]
Bang IS, Liu L, Vazquez-Torres A, Crouch ML, Stamler JS, et al. (2006) Maintenance of nitric oxide and redox homeostasis by the salmonella flavohemoglobin hmp. J Biol Chem 281: 28039–47.
[27]
Mills PC, Rowley G, Spiro S, Hinton JC, Richardson DJ (2008) A combination of cytochrome c nitrite reductase (NrfA) and flavorubredoxin (NorV) protects Salmonella enterica serovar Typhimurium against killing by NO in anoxic environments. Microbiology 154: 1218–28.
[28]
Henard CA, Vázquez-Torres A (2011) Nitric oxide and salmonella pathogenesis. Front. Microbiol 2: 84 doi:10.3389/fmicb.2011.00084.
[29]
Okamura M, Lillehoj HS, Raybourne RB, Babu US, Heckert RA, et al. (2005) Differential responses of macrophages to Salmonella enterica serovars Enteritidis and Typhimurium. Vet Immunol Immunopathol 107: 327–35.
[30]
Withanage GS, Mastroeni P, Brooks HJ, Maskell DJ, McConnell I (2005) Oxidative and nitrosative responses of the chicken macrophage cell line MQ-NCSU to experimental Salmonella infection. Br Poult Sci 46: 261–7.
[31]
Babu US, Gaines DW, Lillehoj H, Raybourne RB (2006) Differential reactive oxygen and nitrogen production and clearance of Salmonella serovars by chicken and mouse macrophages. Dev Comp Immunol 30: 942–53.
[32]
Agbor TA, McCormick BA (2011) Salmonella effectors: important players modulating host cell function during infection. Cell Microbiol 13: 1858–69.
[33]
Rogers LD, Brown NF, Fang Y, Pelech S, Foster LJ (2011) Phosphoproteomic analysis of Salmonella-infected cells identifies key kinase regulators and SopB-dependent host phosphorylation events. Sci. Signal. 4(191): rs9 doi:10.1126/scisignal.2001668.
[34]
Patel JC, Galán JE (2006) Differential activation and function of Rho GTPases during Salmonella-host cell interactions. J Cell Biol 175: 453–63.
[35]
Kuijl C, Savage ND, Marsman M, Tuin AW, Janssen L, et al. (2007) Intracellular bacterial growth is controlled by a kinase network around PKB/AKT1. Nature 450: 725–30.
[36]
Cooper KG, Winfree S, Malik-Kale P, Jolly C, Ireland R, et al. (2011) Activation of Akt by the bacterial inositol phosphatase, SopB, is wortmannin insensitive. PLoS One. 6(7): e22260 doi:10.1371/journal.pone.0022260.
[37]
Mijouin L, Rosselin M, Bottreau E, Pizarro-Cerda J, Cossart P, et al. (2012) Salmonella enteritidis Rck-mediated invasion requires activation of Rac1, which is dependent on the class I PI 3-kinases-Akt signaling pathway. FASEB J 26: 1569–81.
[38]
Wu H, Jones RM, Neish AS (2012) The Salmonella effector AvrA mediates bacterial intracellular survival during infection in vivo. Cell Microbiol 14: 28–39.
[39]
Jones RM, Wu H, Wentworth C, Luo L, Collier-Hyams L, et al. (2008) Salmonella AvrA Coordinates Suppression of Host Immune and Apoptotic Defenses via JNK Pathway Blockade. Cell Host Microbe 3: 233–44.
[40]
Du F, Galán JE (2009) Selective inhibition of type III secretion activated signaling by the Salmonella effector AvrA. PLoS Pathog 5(9): e1000595 doi:10.1371/journal.ppat.1000595.
[41]
Mazurkiewicz P, Thomas J, Thompson JA, Liu M, Arbibe L, et al. (2008) SpvC is a Salmonella effector with phosphothreonine lyase activity on host mitogen-activated protein kinases. Mol Microbiol 67: 1371–83.
[42]
Haneda T, Ishii Y, Shimizu H, Ohshima K, Iida N, et al. (2012) Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection. Cell Microbiol 14: 485–99.
[43]
Lochner A, Moolman JA (2006) The many faces of H89: a review. Cardiovasc. Drug Rev 24: 261–74.
[44]
Uchiya K, Groisman EA, Nikai T (2004) Involvement of Salmonella pathogenicity island 2 in the up-regulation of interleukin-10 expression in macrophages: role of protein kinase A signal pathway. Infect Immun 72: 1964–73.
